Immunome Inc. (IMNM) amends license agreement.
- Amended license agreement with BMS on Oct 2, 2026.
- Removed milestone and royalty payments to BMS.
- Paid $20M cash and issued 4.4M shares to BMS.
IMNM
Immunome Inc. SEC filings
Every EDGAR filing for Immunome Inc. (IMNM), newest first, with AI summaries and stories.
- Ticker
- IMNM
- CIK
- 1472012
- Sector
- Biotech and pharma
- Latest filing
- Oct 5
Next: earnings expected ~Nov 12 · 10-Q expected ~Nov 12 (deadline Nov 16)
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINE8-KImmunome Inc.IMNMLIVE ROUTINE4Immunome Inc.IMNMLIVE Jack Higgins, insider filing for IMNM
Jack Higgins, reporting
ROUTINE144Immunome Inc.IMNMLIVE Jack Higgins, planned sale of IMNM shares
Jack Higgins, reporting
ROUTINESCHEDULE 13G/AImmunome Inc.IMNMLIVE Ownership stake disclosure by T. Rowe Price Investment Management, Inc. (amended)
T. Rowe Price Investment Management, Inc., filed by
ROUTINESCHEDULE 13G/AImmunome Inc.IMNMLIVE Ownership stake disclosure by Sirenia Capital Management LP (amended)
Sirenia Capital Management LP, filed by
ROUTINE4Immunome Inc.IMNMLIVE Isaac Barchas, insider filing for IMNM
Isaac Barchas, reporting
ROUTINE144Immunome Inc.IMNMLIVE Isaac Barchas, planned sale of IMNM shares
Isaac Barchas, reporting
ROUTINES-8Immunome Inc.IMNMLIVE NOTABLE10-QImmunome Inc.IMNMLIVE ROUTINE8-KImmunome Inc.IMNMLIVE ROUTINE4Immunome Inc.IMNMLIVE Isaac Barchas, insider filing for IMNM
Isaac Barchas, reporting
ROUTINE4Immunome Inc.IMNMLIVE Kinney Horn, insider filing for IMNM
Kinney Horn, reporting
ROUTINE144Immunome Inc.IMNMLIVE ABHMC II, LLC, planned sale of IMNM shares
ABHMC II, LLC, reporting
ROUTINE144Immunome Inc.IMNMLIVE Kinney Horn, planned sale of IMNM shares
Kinney Horn, reporting
ROUTINE4Immunome Inc.IMNMLIVE 7 insider filings
Jack Higgins, insider filing for IMNM
Show all 7
- 4Insider filing for IMNM
- 4Insider filing for IMNM
- 4Insider filing for IMNM
- 4Insider filing for IMNM
- 4Insider filing for IMNM
- 4Insider filing for IMNM
- 4Insider filing for IMNM
Jack Higgins, reporting
ROUTINE4Immunome Inc.IMNMLIVE Kinney Horn, insider filing for IMNM
Kinney Horn, reporting
ROUTINE4Immunome Inc.IMNMLIVE Isaac Barchas, insider filing for IMNM
Isaac Barchas, reporting
ROUTINE4Immunome Inc.IMNMLIVE Robert Lechleider, insider filing for IMNM
Robert Lechleider, reporting
ROUTINE144Immunome Inc.IMNMLIVE Kinney Horn, planned sale of IMNM shares
Kinney Horn, reporting
ROUTINE144Immunome Inc.IMNMLIVE ABHMC II, LLC, planned sale of IMNM shares
ABHMC II, LLC, reporting
ROUTINE4Immunome Inc.IMNMLIVE Isaac Barchas, insider filing for IMNM
Isaac Barchas, reporting
ROUTINE144Immunome Inc.IMNMLIVE ABHMC II, LLC, planned sale of IMNM shares
ABHMC II, LLC, reporting
ROUTINE144Immunome Inc.IMNMLIVE Robert Lechleider, planned sale of IMNM shares
Robert Lechleider, reporting
ROUTINE144Immunome Inc.IMNMLIVE 2 Form 144 notices
ABHMC II, LLC, planned sale of IMNM shares
Show all 2
- 144Planned insider sale of IMNM shares
- 144Planned insider sale of IMNM shares
ABHMC II, LLC, reporting
ROUTINE4Immunome Inc.IMNMLIVE Robert Lechleider, insider filing for IMNM
Robert Lechleider, reporting
ROUTINE144Immunome Inc.IMNMLIVE Robert Lechleider, planned sale of IMNM shares
Robert Lechleider, reporting
ROUTINE4Immunome Inc.IMNMLIVE Max Rosett, insider filing for IMNM
Max Rosett, reporting
ROUTINE144Immunome Inc.IMNMLIVE Max Rosett, planned sale of IMNM shares
Max Rosett, reporting
ROUTINE4Immunome Inc.IMNMLIVE 6 insider filings
Sandra M Swain, insider filing for IMNM
Show all 6
- 4Insider filing for IMNM
- 4Insider filing for IMNM
- 4Insider filing for IMNM
- 4Insider filing for IMNM
- 4Insider filing for IMNM
- 4Insider filing for IMNM
Sandra M Swain, reporting
ROUTINE8-KImmunome Inc.IMNMLIVE ROUTINE4Immunome Inc.IMNMLIVE Jean Jacques Bienaime, insider filing for IMNM
Jean Jacques Bienaime, reporting
ROUTINE4Immunome Inc.IMNMLIVE Jean Jacques Bienaime, insider filing for IMNM
Jean Jacques Bienaime, reporting
ROUTINESCHEDULE 13G/AImmunome Inc.IMNMLIVE 2 13G filings
Ownership stake disclosure by Point72 Asset Management, L.P. (amended)
Show all 2
- SCHEDULE 13G/AOwnership stake disclosure (amended)
- SCHEDULE 13G/AOwnership stake disclosure (amended)
Point72 Asset Management, L.P., filed by
ROUTINESCHEDULE 13G/AImmunome Inc.IMNMLIVE Ownership stake disclosure by T. Rowe Price Investment Management, Inc. (amended)
T. Rowe Price Investment Management, Inc., filed by
ROUTINESCHEDULE 13GImmunome Inc.IMNMLIVE Ownership stake disclosure by Sirenia Capital Management LP
Sirenia Capital Management LP, filed by
ROUTINE8-KImmunome Inc.IMNMLIVE NOTABLE10-QImmunome Inc.IMNMLIVE